Nexviadyme
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nexviadyme, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: EMA Authorised: Nexviadyme (avalglucosidase alfa) — Sanofi B.V.
1 regulatory and trial event tracked for Nexviadyme, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: EMA Authorised: Nexviadyme (avalglucosidase alfa) — Sanofi B.V.